| II-59 Maarten Van Eijk Optimizing the value of preclinical data for the design of first-in-human clinical studies with oral cabazitaxel through population pharmacokinetic modelling Wednesday 15:10-16:40 |
| II-59 Maarten Van Eijk Optimizing the value of preclinical data for the design of first-in-human clinical studies with oral cabazitaxel through population pharmacokinetic modelling Wednesday 15:10-16:40 |